Quench Medical is developing a novel aerosol platform technology to deliver medicine into deep areas of the lung.
Quench Medical is developing a novel aerosol platform technology to deliver medicine into deep areas of the lung with unprecedented efficiency to greatly increase efficacy in treating pulmonary airway diseases. The primary application of this technology is an inhaled chemotherapy medication to treat lung cancer by directly targeting lung tumors and minimizing systemic toxicity.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 26, 2018 | Non-Equity Assistant | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
gener8tor | — | Non-Equity Assistant |